224 related articles for article (PubMed ID: 20684152)
1. Progressive multifocal leukoencephalopathy in two psoriasis patients treated with efalizumab.
Gadzia J; Turner J
J Drugs Dermatol; 2010 Aug; 9(8):1005-9. PubMed ID: 20684152
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.
Kothary N; Diak IL; Brinker A; Bezabeh S; Avigan M; Dal Pan G
J Am Acad Dermatol; 2011 Sep; 65(3):546-551. PubMed ID: 21514689
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy and antipsoriatic drugs: assessing the risk of immunosuppressive treatments.
Di Lernia V
Int J Dermatol; 2010 Jun; 49(6):631-5. PubMed ID: 20618466
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.
Korman BD; Tyler KL; Korman NJ
Arch Dermatol; 2009 Aug; 145(8):937-42. PubMed ID: 19687432
[No Abstract] [Full Text] [Related]
5. [Progressive multifocal leukoencephalopathy in a patient with multiple myeloma].
Willert CB; Engsig FN; Eskildsen HW; Andersen AB
Ugeskr Laeger; 2014 Dec; 176(49):. PubMed ID: 25497861
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy and newer biological agents.
Berger JR
Drug Saf; 2010 Nov; 33(11):969-83. PubMed ID: 20925435
[TBL] [Abstract][Full Text] [Related]
7. Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.
Schwab N; Ulzheimer JC; Fox RJ; Schneider-Hohendorf T; Kieseier BC; Monoranu CM; Staugaitis SM; Welch W; Jilek S; Du Pasquier RA; Brück W; Toyka KV; Ransohoff RM; Wiendl H
Neurology; 2012 Feb; 78(7):458-67; discussion 465. PubMed ID: 22302546
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy.
Ladizinski B; Heller MM; Bhutani T; Zitelli KB; Koo JY
J Drugs Dermatol; 2013 Feb; 12(2):e20-4. PubMed ID: 23377400
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies and progressive multifocal leukoencephalopathy.
Berger JR; Houff SA; Major EO
MAbs; 2009; 1(6):583-9. PubMed ID: 20073129
[TBL] [Abstract][Full Text] [Related]
10. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Tavazzi E; Ferrante P; Khalili K
Clin Microbiol Infect; 2011 Dec; 17(12):1776-80. PubMed ID: 22082208
[TBL] [Abstract][Full Text] [Related]
12. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature.
Verhelst X; Vanhooren G; Vanopdenbosch L; Casselman J; Laleman W; Pirenne J; Nevens F; Orlent H
Transpl Int; 2011 Apr; 24(4):e30-4. PubMed ID: 21134241
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS; Koralnik IJ
Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
[TBL] [Abstract][Full Text] [Related]
15. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
[TBL] [Abstract][Full Text] [Related]
16. [Targeted therapy and progressive multifocal leukoencephalopathy (PML): PML in the era of monoclonal antibody therapies].
Takao M
Brain Nerve; 2013 Nov; 65(11):1363-74. PubMed ID: 24200614
[TBL] [Abstract][Full Text] [Related]
17. [Progressive multifocal leukoencephalopathy].
Pál E; Aschermann Z; Gömöri E; Kovács GG; Simon G; Maródi L; Komoly S; Illés Z
Ideggyogy Sz; 2007 May; 60(5-6):263-8. PubMed ID: 17578275
[TBL] [Abstract][Full Text] [Related]
18. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome.
Dumortier J; Guillaud O; Bosch A; Coppéré B; Petiot P; Roggerone S; Vukusic S; Boillot O
Transpl Infect Dis; 2016 Aug; 18(4):606-10. PubMed ID: 27224849
[TBL] [Abstract][Full Text] [Related]
20. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus.
Ramadhani P; Bramantono B; Sedana MP
Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]